Skip to main content

Table 1 Comparison of the baseline characteristics between the two groups

From: A nonrandomized controlled trial of individualized exercise prescription combined with remote exercise management in patients who are overweight or obese

  Experimental group (n = 55)
Before intervention
Control group (n = 34)
Before intervention
t P
Weight (kg) 78.54 ± 12.58 75.29 ± 12.71 −1.180 0.241
BMI (kg/m2) 27.86 ± 3.17 27.59 ± 2.81 −0.399 0.691
WC (cm) 89.27 ± 7.85 88.66 ± 9.12 −0.355 0.738
HC (cm) 101.36 ± 5.73 101.19 ± 6.89 −0.128 0.899
SBP (mmHg) 127.20 ± 16.60 124.85 ± 15.50 −0.664 0.504
DBP(mmHg) 77.13 ± 10.78 76.97 ± 13.28 −0.061 0.952
VC (cm2) 83.31 ± 32.82 80.43 ± 33.49 −0.399 0.691
BF (kg) 26.39 ± 6.45 26.78 ± 5.04 0.299 0.706
SMC (kg) 28.99 ± 6.27 27.11 ± 6.28 −1.380 0.171
BF (%) 33.55 ± 6.34 35.61 ± 5.14 1.594 0.114
UA (µmol/L) 361.96 ± 96.55 322.12 ± 90.45 −1.937 0.056
TC (mmol/L) 4.52 ± 0.71 4.76 ± 0.81 1.495 0.139
TG (mmol/L) 1.37 ± 0.65 1.57 ± 1.42 0.919 0.361
LDL-C (mmol/L) 1.20 ± 0.19 1.29 ± 0.21 1.865 0.066
HDL-C (mmol/L) 2.77 ± 0.67 2.87 ± 0.66 0.752 0.454
HbA1c (%) 5.60 ± 0.45 5.58 ± 0.38 −0.184 0.855
FBG (mmol/L) 5.21 ± 0.62 5.07 ± 0.47 −1.129 0.262
FI (μU/mL) 11.16 ± 5.34 11.45 ± 5.52 0.247 0.805
HOMA-IR 2.59 ± 1.40 2.58 ± 1.25 −0.027 0.978
  1. WC waist circumference, HC hip circumference, SBP systolic blood pressure, DBP diastolic blood pressure, VFA visceral fat area, BF body fat, SMC skeletal muscle content, UA uric acid, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, HbA1c hemoglobin A1c, FBG fasting blood glucose, FI fasting insulin, HOMA-IR homeostatic model assessment of insulin resistance